kentucky glp-1 constipation lawsuit Risks of Ozempic, other drugs are at center of sweeping that kicked off in Philadelphia As GLP-1 weight-loss drugs surged
Description
The company has acquired a European competitor, Zava, which already has 1.3 million customers for a range of productsincluding some obesity treatmentsin the UK, Ireland, Germany and France
De Giorgi and colleagues present a comprehensive analysis of pre-clinical and clinical studies examining the role of glucagon-like peptide-1 receptor agonists in mental disorders.
LMNT reports that GLP-1 medications for obesity and diabetes may lead to electrolyte imbalances, highlighting hydration strategies for users.
Carey MD Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore
